x

WE'RE COMMITTED TO YOU

VIEW MESSAGE FROM NEURELIS, INC., PRESIDENT AND CHIEF EXECUTIVE OFFICER ABOUT THE COVID-19 PANDEMIC

READ MORE

DEFINE YOUR NEU NORMAL

At Neurelis, we don’t back down from challenges––we’re inspired to innovate meaningful solutions. We see possibilities rather than limitations for people living with neurological conditions. That’s why we are dedicated to developing life-changing treatments that empower people to define their own journey.

OUR PRODUCT

We have reached a milestone in patient care with the first FDA-approved treatment from Neurelis.

LEARN MORE

OUR SAVINGS AND SUPPORT PROGRAM

We want to ensure that people with neurological conditions using our innovative therapies get the support and savings they need to stay on treatment.

LEARN MORE

OUR PIPELINE

Our pipeline currently includes several investigational product candidates at various stages of development.

LEARN MORE

OUR TECHNOLOGIES

Neurelis has a proprietary technology portfolio that includes Intravail®, ProTek®, and Hydrogel™ for drug delivery enhancement. These three non-invasive drug delivery and stabilization technologies are applicable to a wide range of molecules, including therapeutic proteins, peptides, and non-peptide large and small molecules. Our technologies offer exceptional potential value in enhancing drug development and clinical performance.

LEARN MORE

ABOUT NEURELIS

Neurelis is a neuroscience-based company dedicated to enhancing therapeutic benefit and addressing unmet needs in care for people with neurological conditions.

LEARN MORE

KEEP CURRENT

Get the most up-to-date information about Neurelis and our products.

READ MORE

HAVE A QUESTION ABOUT NEURELIS?

Please contact us if you have any questions about Neurelis or any of the products we are currently developing. 

Contact Us